Protein-Protein Interactions in Human Disease, Part A
- 1st Edition, Volume 110 - January 24, 2018
- Editor: Rossen Donev
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 1 4 3 4 4 - 5
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 4 3 4 5 - 2
Protein-Protein Interactions in Human Disease, Part A, Volume 110 aims to promote further research and development in the protein interaction network as a means to not only iden… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteProtein-Protein Interactions in Human Disease, Part A, Volume 110 aims to promote further research and development in the protein interaction network as a means to not only identify the critical proteins involved in the etiology of human diseases, but also identify new protein targets for drug development. Sections cover such topics as protein-protein interaction modulators for epigenetic therapies, intrinsic disorder, protein-protein interactions and disease, targeting protein-protein interactions in the ubiquitin-proteasome pathway, the proteomics of occupational diseases, and computational methods in predicting the impact of SNPs in protein-protein network, amongst other topics.
- Describes advances in the application of powerful techniques in studying and analyzing protein-protein interactions
- Targeted to a wide audience of researchers, specialists and students
- Written by authorities in their field
- Includes information that is well supported by a number of high quality illustrations, figures and tables
Protein chemists, pharmacologists, cell biologists, immunologists, structural biologists, computational biochemists and other researchers working in this field. Articles published here would also be of a great benefit to medical, biology and pharmacology students specializing in this field
1. Analysis of protein interactions by surface plasmon resonance
Dennis G. Drescher
2. Using TR-FRET to investigate protein-protein interactions: a case study of PXR-coregulator interaction
Taosheng Chen
3. Protein-Protein Interaction Modulators for Epigenetic Therapies
Jose L. Medina-Franco
4. Intrinsic disorder, protein-protein interactions and disease
Vladimir N. Uversky
5. Targeting protein-protein interactions in the ubiquitin-proteasome pathway
Maria Gaczynska
6. Protein-protein networks involved in MODY family
George Priya Doss P. C
7. Defining HIV-1 replication mechanisms by analyzing virus-host protein interactions
Manuel Llano
8. Proteomics of occupational diseases
Nicola Luigi Bragazzi
9. Proteomics of sport-related injuries
Nicola Luigi Bragazzi
10. Structural prediction of protein-protein interactions by docking: application to biomedical problems
Juan Fernandez-Recio
11. Computational methods in predicting the impact of SNPs in Protein-protein network
George Priya Doss P. C
- No. of pages: 288
- Language: English
- Edition: 1
- Volume: 110
- Published: January 24, 2018
- Imprint: Academic Press
- Hardback ISBN: 9780128143445
- eBook ISBN: 9780128143452
RD
Rossen Donev
Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.
Affiliations and expertise
Head of Research, MicroPharm Limited, UKRead Protein-Protein Interactions in Human Disease, Part A on ScienceDirect